The clinical evidences have been obtained from breast cancer patients, where after intra tumor injection, tumors displayed necrosis, loss of c-MET and infiltration of macrophages
But the patient should know the combination has no trial data behind it, the additional cost is real, and the marginal benefit is unproven
doi: 10.1021/acs.langmuir.6b01848
One documented case involved a 45-year-old tennis player with a partial rotator cuff tear who had found limited relief from traditional treatments
Consult with your healthcare provider, choose high-quality supplements, follow recommended dosages, and monitor your body's response to any new supplement
2 REIMAGINE 3 was a 40-week phase 3 trial evaluating the safety and efficacy of CagriSema 2.4 mg/2.4 mg and 1 mg/1 mg once weekly versus dose-matched placebo in 274 adults with T2D as add-on to once-daily basal insulin with or without metformin